Jeff Vanderwielen
AUTHOR

Jeff Vanderwielen

Tap the gear icon above to manage new release emails.
Jeff Vanderwielen, PhD is an organization development expert who translates emerging trends in the sustainability and purpose landscape into actionable, results-driven initiatives for clients. He brings 20-plus years of experience helping global organizations articulate a compelling purpose - their core good - as the organizing center for their vision, strategy, and culture. Dr. Vanderwielen has facilitated hundreds of interactive workshops with top organizations, using simulations, stories, and iterative engagement processes to help leaders learn by doing. He is a former change consultant with Ernst & Young with extensive experience as a coach to global leaders, facilitating strategic planning and helping organizations manage complex change efforts. His clients have included Chevron, Conagra Brands, Merck, Northrup Grumman, UBS, IPG, Amgen, BC Hydro, Gateway Computers, Ascension Health, Sustainable Brands, Trinity Health, SDG&E, and UC San Diego Medical Center.
Read more Read less

Best Sellers

Product List
  • ₹836.00 or free with 30-day trial

  • ₹284.00 Regular price:

  • ₹669.00 or free with 30-day trial

  • ₹668.00 Regular price:

  • ₹668.00 Regular price:

  • ₹1,003.00 or free with 30-day trial

  • ₹122.00 Regular price:

  • ₹501.00 Regular price:

  • ₹759.00 or free with 30-day trial

  • ₹961.00 or free with 30-day trial

  • ₹1,003.00 or free with 30-day trial

  • ₹254.00 Regular price:

  • ₹501.00 Regular price:

    • An Indispensible Primer on the Ultimate Form of Power
    • Written by: Robert Greene
    • Narrated by: Joseph Powers
    • Length: 22 hrs and 51 mins
    • Release Date: 01-05-15
    • Language: English
    • 4.5 out of 5 stars 159 ratings

    ₹820.00 or free with 30-day trial

  • ₹1,171.00 or free with 30-day trial

  • ₹398.00 or free with 30-day trial

  • ₹586.00 or free with 30-day trial

  • ₹199.00 Regular price:

  • ₹1,003.00 Regular price:

  • ₹69.00 or free with 30-day trial